Here you will find the archive of past SCALLOP news, as well as links to the latest news posts
June 2021
New clinical trials arm for SCALLOP projects
In a short video presentation, Anders Mälarstig outlines a new collaborative initiative from SCALLOP to optimize the power of proteomic profiling in early clinical trials, sharing data to overcome the low sample numbers available from phase I/II trials. This initiative is also the subject of a recent Olink press release – READ IT HERE
If you are unable to watch this video from YouTube – please CLICK HERE
May 2021
New editorial article in SelectScience
Based on an exclusive interview with Anders Mälarstig, “Harnessing cutting-edge proteogenomics in the quest for novel drug targets” discusses how collaborative research between big pharma and academia is using the latest proteomics platforms to revolutionize drug discovery. Read it here
